农村患者/护理人员心力衰竭患者所经历的自我护理问题和管理策略:一项定性研究
The Journal of cardiovascular nursing
|November 13, 2023
概括
农村心力衰竭 (HF) 患者/护理人员双组面临独特的自我护理挑战. 互惠和关系动态显著影响在家中管理HF,突出需要量身定制的支持.
科学领域:
- 心脏病学 心脏病学
- 老年学是指老年学的学科.
- 农村卫生 农村卫生
背景情况:
- 农村心力衰竭患者的死亡率和住院率高于城市患者.
- 非正式的护理人员对于HF自我护理至关重要,但农村患者/护理人员双重面临的挑战未得到充分研究.
- 有限的数据存在于农村二元体在家里管理高温热量时遇到的具体问题及其管理策略.
研究的目的:
- 识别和描述农村患者/护理人员双组在家庭环境中生活在HF中所经历的自我护理问题.
- 探索这些已识别的高频率自我护理问题是如何被农村两会管理的.
- 了解农村二元期内HF自我护理管理的贡献因素.
主要方法:
- 使用个人,半结构化的电话采访进行描述性的定性设计.
- 数据与分析同时收集,直到达到主题和.
- 对11个农村患者/护理人员二组的采访数据进行了图形内容分析.
主要成果:
- 四个主要主题出现了:HF自我护理组件,环境因素 (农村障碍,COVID-19),照顾者的贡献 (信心,角色) 和二元贡献者 (关系).
- 迪亚德报告了各种各样的自我照顾问题,关系质量和互惠关系影响了解决问题和管理策略的制定.
- 患者平均年龄为65.3岁,护理人员平均年龄为62岁.
结论:
- 调查结果突出了农村HF双所面临的复杂的自我护理问题,以及两个成员在管理中的不可或缺的作用.
- 确定的主题强调了对文化敏感的干预措施的需要,这些干预措施专门为患有高风的农村患者/护理人员二极管设计.
- 双层关系的动态对于农村环境中有效的高频自我护理管理至关重要.
相关概念视频
01:30Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
01:29Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
01:22Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
01:30Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
01:25Dysrhythmias VII: Nursing Management of Dysrhythmias
13
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
13
01:20Rheumatic Heart Disease IV: Nursing Management
14
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
14